Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hu14.18-IL2 with GM-CSF and Isotretinoin for Relapsed/Refractory Neuroblastoma
NCT01334515Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 2011
- Primary completion
- Dec 2013
- Countries
- 2
01
Overview
A Phase 2 trial of Lorukafusp alfa in neuroblastoma, sponsored by Children's Oncology Group. Started Sep 2011; status: completed.
02
Drugs
Lorukafusp alfa
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01334515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334515.